logo

For the Inventor, By the Inventor

Arlesheim, Switzerland

Andreas Dominik Christ

This inventor holds 10 USPTO granted patents and 3 published patent applications. Top assignee: Hoffmann-La Roche Inc.. Active years: 2010-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas Dominik Christ. Retrieved from https://idiyas.com/inventor/andreas-dominik-christ

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 14(Granted Patents)


Location History:

  • Arleshein, CH (2010)
  • Arlesheim, CH (2010 - 2011)
  • Arleshiem, CH (2011)

Company Filing History:

goldMedal10 out of 5,026 
 
Hoffmann-La Roche Inc.
 patents

Years Active: 2010-2011

Loading Chart...
10 patents (USPTO):Explore Patents
1. 8026365 - 4,4-disubstituted piperidine derivatives (2011-09-27),
2. 8026255 - Substituted piperidines as somatostatin receptor subtype 5 (SSTR5) antagonists (2011-09-27),
3. 7968568 - Substituted piperidine derivatives as SST5 modulators (2011-06-28),
4. 7939661 - Pyridine, quinoline and pyrimidine derivatives (2011-05-10),
5. 7855194 - Pyrimidine, quinazoline, pteridine and triazine derivatives (2010-12-21),
6. 7799806 - Substituted n-benzyl piperidines as somatostatin receptor modulators (2010-09-21),
7. 7772253 - Amide derivatives as somatostatin receptor 5 antagonists (2010-08-10),
8. 7754744 - Substituted piperidinamines as somatostatin receptor subtype 5 (SSTR5) antagonists (2010-07-13),
9. 7674804 - Pyrimidine and quinazoline derivatives as SST5 modulators (2010-03-09),
10. 7645753 - Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives (2010-01-12),

Title: The Innovations of Andreas Dominik Christ

Introduction

Andreas Dominik Christ is a notable inventor based in Arlesheim, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the body. With a total of 10 patents to his name, his work has the potential to impact the treatment of various diseases.

Latest Patents

Among his latest patents are the inventions related to 4,4-disubstituted piperidine derivatives. This invention focuses on compounds that can be used in pharmaceutical compositions for the treatment and prevention of diseases associated with the modulation of SST receptors subtype 5. Another significant patent involves substituted piperidines as somatostatin receptor subtype 5 (SSTR5) antagonists, which also aims to provide therapeutic solutions for similar medical conditions.

Career Highlights

Andreas Christ is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at this esteemed organization has allowed him to further his research and development efforts in creating innovative medical solutions.

Collaborations

Throughout his career, Andreas has collaborated with notable colleagues, including Rainer Eugen Martin and Alfred Binggeli. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Andreas Dominik Christ's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through targeted therapies. His work continues to pave the way for advancements in the treatment of diseases linked to SST receptors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…